Log in
NASDAQ:AXNX

Axonics Modulation Technologies Stock Forecast, Price & News

$50.32
+0.39 (+0.78 %)
(As of 10/27/2020 12:00 AM ET)
Add
Compare
Today's Range
$47.44
Now: $50.32
$50.82
50-Day Range
$35.33
MA: $45.80
$51.04
52-Week Range
$15.25
Now: $50.32
$52.10
Volume702,831 shs
Average Volume633,121 shs
Market Capitalization$1.99 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.09
Axonics Modulation Technologies, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems in the United States and internationally. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence, and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company was formerly known as American Restorative Medicine, Inc. and changed its name to Axonics Modulation Technologies, Inc. in August 2013. Axonics Modulation Technologies, Inc. was incorporated in 2012 and is based in Irvine, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.39 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AXNX
CUSIPN/A
CIKN/A
Phone949-396-6322
Employees302

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$13.82 million
Book Value$6.40 per share

Profitability

Net Income$-79,930,000.00
Net Margins-155.91%

Miscellaneous

Market Cap$1.99 billion
Next Earnings Date11/4/2020 (Confirmed)
OptionableNot Optionable
$50.32
+0.39 (+0.78 %)
(As of 10/27/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AXNX News and Ratings via Email

Sign-up to receive the latest news and ratings for AXNX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Axonics Modulation Technologies (NASDAQ:AXNX) Frequently Asked Questions

How has Axonics Modulation Technologies' stock been impacted by Coronavirus?

Axonics Modulation Technologies' stock was trading at $30.22 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, AXNX shares have increased by 66.5% and is now trading at $50.32.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Axonics Modulation Technologies?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Axonics Modulation Technologies in the last year. There are currently 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Axonics Modulation Technologies
.

When is Axonics Modulation Technologies' next earnings date?

Axonics Modulation Technologies is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Axonics Modulation Technologies
.

How can I listen to Axonics Modulation Technologies' earnings call?

Axonics Modulation Technologies will be holding an earnings conference call on Wednesday, November 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Axonics Modulation Technologies' earnings last quarter?

Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) issued its quarterly earnings data on Thursday, August, 6th. The company reported ($0.54) earnings per share for the quarter, beating analysts' consensus estimates of ($0.65) by $0.11. The company had revenue of $15.21 million for the quarter, compared to analyst estimates of $5.06 million. Axonics Modulation Technologies had a negative return on equity of 44.13% and a negative net margin of 155.91%. Axonics Modulation Technologies's revenue for the quarter was up 922.4% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.68) EPS.
View Axonics Modulation Technologies' earnings history
.

What price target have analysts set for AXNX?

9 Wall Street analysts have issued 12-month target prices for Axonics Modulation Technologies' shares. Their forecasts range from $39.00 to $77.00. On average, they anticipate Axonics Modulation Technologies' share price to reach $52.56 in the next year. This suggests a possible upside of 4.4% from the stock's current price.
View analysts' price targets for Axonics Modulation Technologies
.

Who are some of Axonics Modulation Technologies' key competitors?

What other stocks do shareholders of Axonics Modulation Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Axonics Modulation Technologies investors own include Raytheon Technologies (RTX), Honeywell International (HON), Oasis Petroleum (OAS), Pfizer (PFE), The Procter & Gamble (PG), Thermo Fisher Scientific (TMO), Cisco Systems (CSCO), CVS Health (CVS), AT&T (T) and Abbott Laboratories (ABT).

Who are Axonics Modulation Technologies' key executives?

Axonics Modulation Technologies' management team includes the following people:
  • Mr. Raymond W. Cohen, CEO & Director (Age 61, Pay $871.2k)
  • Mr. Danny L. Dearen, Pres & CFO (Age 57, Pay $636.2k)
  • Mr. Rinda K. Sama, Chief Operating Officer (Age 41, Pay $536.2k)
  • Mr. Guangqiang Jiang Ph.D., Chief Technology Officer (Age 47)
  • Mr. Neil Bhalodkar, VP of Investor Relations

When did Axonics Modulation Technologies IPO?

(AXNX) raised $100 million in an IPO on Wednesday, October 31st 2018. The company issued 6,700,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and Morgan Stanley served as the underwriters for the IPO and Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

What is Axonics Modulation Technologies' stock symbol?

Axonics Modulation Technologies trades on the NASDAQ under the ticker symbol "AXNX."

Who are Axonics Modulation Technologies' major shareholders?

Axonics Modulation Technologies' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Peregrine Capital Management LLC (1.32%), Rhenman & Partners Asset Management AB (1.16%), Columbus Circle Investors (0.35%), Nachman Norwood & Parrott Inc (0.00%) and Nisa Investment Advisors LLC (0.00%). Company insiders that own Axonics Modulation Technologies stock include Alfred J Ford, Jr, Andera Partners, Bakker Juliet Tammenoms, Cormorant Asset Management, Lp, Danny L Dearen, Geoff Pardo, Healthcare Holding BV Gilde, John Woock, Michael V Williamson, Nancy Lynn Md Snyderman, Raphael Wisniewski, Raymond W Cohen and Rinda Sama.
View institutional ownership trends for Axonics Modulation Technologies
.

Which institutional investors are selling Axonics Modulation Technologies stock?

AXNX stock was sold by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, and Rhenman & Partners Asset Management AB. Company insiders that have sold Axonics Modulation Technologies company stock in the last year include Alfred J Ford, Jr, Andera Partners, Bakker Juliet Tammenoms, Danny L Dearen, John Woock, Raphael Wisniewski, Raymond W Cohen, and Rinda Sama.
View insider buying and selling activity for Axonics Modulation Technologies
.

Which institutional investors are buying Axonics Modulation Technologies stock?

AXNX stock was purchased by a variety of institutional investors in the last quarter, including Columbus Circle Investors, Nachman Norwood & Parrott Inc, and Nisa Investment Advisors LLC. Company insiders that have bought Axonics Modulation Technologies stock in the last two years include Bakker Juliet Tammenoms, Cormorant Asset Management, Lp, Healthcare Holding BV Gilde, Nancy Lynn Md Snyderman, and Raymond W Cohen.
View insider buying and selling activity for Axonics Modulation Technologies
.

How do I buy shares of Axonics Modulation Technologies?

Shares of AXNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Axonics Modulation Technologies' stock price today?

One share of AXNX stock can currently be purchased for approximately $50.32.

How big of a company is Axonics Modulation Technologies?

Axonics Modulation Technologies has a market capitalization of $1.99 billion and generates $13.82 million in revenue each year. The company earns $-79,930,000.00 in net income (profit) each year or ($2.80) on an earnings per share basis. Axonics Modulation Technologies employs 302 workers across the globe.

What is Axonics Modulation Technologies' official website?

The official website for Axonics Modulation Technologies is www.axonics.com.

How can I contact Axonics Modulation Technologies?

Axonics Modulation Technologies' mailing address is 26 TECHNOLOGY DRIVE, IRVINE CA, 92618. The company can be reached via phone at 949-396-6322.

This page was last updated on 10/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.